Unknown Indication — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for unknown indication. 54 active patents protecting 4 drugs from 0+ originators. First major cliff: 2026. Daily refresh.

4
Approved drugs
54
Active US patents
70/100
Avg vulnerability
—
Annual revenue covered

Originators in Unknown Indication

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating unknown indication. Each bar = one year. Y-axis scaled to peak year (24 patents).

1
26
24
27
1
28
2
31
2
35
2
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
NICARDIPINE HYDROCHLORIDE — 44 72 — 2027-04-18
TELOTRISTAT ETIPRATE — 5 49 — 2027-12-11
DANICOPAN — 4 75 — 2035-02-25
SINECATECHINS — 1 85 — 2026-10-02

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11547758 NICARDIPINE HYDROCHLORIDE method of use 88 2027-04-18
11547758 NICARDIPINE HYDROCHLORIDE method of use 88 2027-04-18
11547758 NICARDIPINE HYDROCHLORIDE method of use 88 2027-04-18
7858662 SINECATECHINS method of use 85 2026-10-02
8455524 NICARDIPINE HYDROCHLORIDE method of use 85 2027-04-18
7659291 NICARDIPINE HYDROCHLORIDE method of use 85 2027-04-18
7659291 NICARDIPINE HYDROCHLORIDE method of use 85 2027-04-18
7659291 NICARDIPINE HYDROCHLORIDE method of use 85 2027-04-18
8455524 NICARDIPINE HYDROCHLORIDE method of use 85 2027-04-18
7659291 NICARDIPINE HYDROCHLORIDE method of use 85 2027-04-18

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8193204 TELOTRISTAT ETIPRATE composition of matter 10 2031-02-27
7553840 TELOTRISTAT ETIPRATE composition of matter 17 2027-12-11
9364564 NICARDIPINE HYDROCHLORIDE formulation 55 2027-12-26
9364564 NICARDIPINE HYDROCHLORIDE formulation 55 2027-12-26
9364564 NICARDIPINE HYDROCHLORIDE formulation 55 2027-12-26
9364564 NICARDIPINE HYDROCHLORIDE formulation 55 2027-12-26
7612102 NICARDIPINE HYDROCHLORIDE formulation 60 2027-12-26
7612102 NICARDIPINE HYDROCHLORIDE formulation 60 2027-12-26
7612102 NICARDIPINE HYDROCHLORIDE formulation 60 2027-12-26
7612102 NICARDIPINE HYDROCHLORIDE formulation 60 2027-12-26

Related